Literature DB >> 3926460

Presence and localization of two vitamin D-dependent calcium binding proteins in kidneys of higher vertebrates.

W B Rhoten, M E Bruns, S Christakos.   

Abstract

We looked for the presence of vitamin D-dependent intestinal calcium binding protein (CaBP), relative molecular mass (mol wt) about 10,000, in kidneys of mammals, birds, and reptiles, and compared the localization of this 10,000 mol wt CaBP with the localization of the 28,000 mol wt vitamin D-dependent CaBP. Antiserum directed against rat intestinal CaBP (RICaBP) was used with the unlabeled antibody peroxidase-antiperoxidase technique to localize the 10,000 mol wt CaBP. Kidneys of adult Swiss and DBA/2J mice were positive for the 10,000 mol wt CaBP, whereas kidneys of adult rat, chicken, and two species of lizard were negative. Extracts of adult rat kidney showed no detectable immunoreactivity with the antiserum to RICaBP by radial immunodiffusion assay. However, kidneys of postnatal rats (12 days old) exhibited limited immunocytochemical reactivity and relatively low immunoreactivity (about 1 micrograms/mg protein) for 10,000 mol wt CaBP. In both strains of mice, 10,000 mol wt CaBP was localized predominantly to the distal convoluted tubules, connecting tubules, and collecting tubules of the cortical labyrinth. In 12-day-old rats 10,000 mol wt CaBP was localized to the distal convoluted tubules and cortical ascending thick limbs. Absorption of the antiserum with electrophoretically pure RICaBP eliminated specific reactivity. By dual color staining of mouse kidneys, the population of cells reactive for the 10,000 mol wt CaBP was found to be similar, but not identical, to that population of cells reactive for the 28,000 mol wt CaBP. Absorption of the antiserum to RICaBP with either rat renal CaBP or chicken intestinal CaBP (both 28,000 mol wt CaBPs) had no affect on the positive reactivity of the distal mouse nephron for RICaBP. Conversely, absorption of the antiserum to rat renal CaBP with the 10,000 mol wt RICaBP had no affect on reactivity for the 28,000 mol wt CaBP. Thus, two immunologically distinct CaBPs, mol wt 10,000 and 28,000, are present in the adult mouse nephron; whereas, kidneys of adult rats, chickens, and saurian reptiles apparently contain significant levels of only 28,000 mol wt CaBP. Since the 12-day-old rat nephron contains both the 28,000 mol wt and the 10,000 mol wt CaBP it appears that in the kidney, ontogenetically, and perhaps evolutionarily as well, the 28,000 mol wt CaBP is more highly conserved.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926460     DOI: 10.1210/endo-117-2-674

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Calbindins decreased after space flight.

Authors:  I N Sergeev; W B Rhoten; M D Carney
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

2.  Intracellular calcium ion response to glucose in beta-cells of calbindin-D28k nullmutant mice and in betaHC13 cells overexpressing calbindin-D28k.

Authors:  Jai Parkash; Muhammad A Chaudhry; Ayman S Amer; Sylvia Christakos; William B Rhoten
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

3.  Use of dual section mRNA in situ hybridisation/immunohistochemistry to clarify gene expression patterns during the early stages of nephron development in the embryo and in the mature nephron of the adult mouse kidney.

Authors:  Kylie Georgas; Bree Rumballe; Lorine Wilkinson; Han Sheng Chiu; Emmanuelle Lesieur; Thierry Gilbert; Melissa H Little
Journal:  Histochem Cell Biol       Date:  2008-07-11       Impact factor: 4.304

Review 4.  Distal convoluted tubule.

Authors:  James A McCormick; David H Ellison
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

5.  Gestational changes in calbindin-D9k in rat uterus, yolk sac, and placenta: implications for maternal-fetal calcium transport and uterine muscle function.

Authors:  C L Mathieu; S H Burnett; S E Mills; J G Overpeck; D E Bruns; M E Bruns
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Renal cell markers: lighthouses for managing renal diseases.

Authors:  Shivangi Agarwal; Yashwanth R Sudhini; Onur K Polat; Jochen Reiser; Mehmet M Altintas
Journal:  Am J Physiol Renal Physiol       Date:  2021-10-11

7.  Generation of Functional Organs Using a Cell-Competitive Niche in Intra- and Inter-species Rodent Chimeras.

Authors:  Toshiya Nishimura; Fabian P Suchy; Joydeep Bhadury; Kyomi J Igarashi; Carsten T Charlesworth; Hiromitsu Nakauchi
Journal:  Cell Stem Cell       Date:  2020-12-28       Impact factor: 24.633

8.  Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Mrinal M Gounder; Albiruni Abdul Razak; Neeta Somaiah; Sant Chawla; Javier Martin-Broto; Giovanni Grignani; Scott M Schuetze; Bruno Vincenzi; Andrew J Wagner; Bartosz Chmielowski; Robin L Jones; Richard F Riedel; Silvia Stacchiotti; Elizabeth T Loggers; Kristen N Ganjoo; Axel Le Cesne; Antoine Italiano; Xavier Garcia Del Muro; Melissa Burgess; Sophie Piperno-Neumann; Christopher Ryan; Mary F Mulcahy; Charles Forscher; Nicolas Penel; Scott Okuno; Anthony Elias; Lee Hartner; Tony Philip; Thierry Alcindor; Bernd Kasper; Peter Reichardt; Lore Lapeire; Jean-Yves Blay; Christine Chevreau; Claudia Maria Valverde Morales; Gary K Schwartz; James L Chen; Hari Deshpande; Elizabeth J Davis; Garth Nicholas; Stefan Gröschel; Helen Hatcher; Florence Duffaud; Antonio Casado Herráez; Roberto Diaz Beveridge; Giuseppe Badalamenti; Mikael Eriksson; Christian Meyer; Margaret von Mehren; Brian A Van Tine; Katharina Götze; Filomena Mazzeo; Alexander Yakobson; Aviad Zick; Alexander Lee; Anna Estival Gonzalez; Andrea Napolitano; Mark A Dickson; Dayana Michel; Changting Meng; Lingling Li; Jianjun Liu; Osnat Ben-Shahar; Dane R Van Domelen; Christopher J Walker; Hua Chang; Yosef Landesman; Jatin J Shah; Sharon Shacham; Michael G Kauffman; Steven Attia
Journal:  J Clin Oncol       Date:  2022-04-08       Impact factor: 50.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.